Loading…

ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer

Ethylmalonic Encephalopathy Protein 1 ( ) is a sulfur dioxygenase that regulates cellular H S levels. We previously demonstrated a significant increase of expression in "single-hit" colon epithelial cells from crypts of patients with Familial Adenomatous Polyposis (FAP). Here, we report el...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2019-06, Vol.10 (40), p.4004-4017
Main Authors: Witherspoon, Mavee, Sandu, Davinder, Lu, Changyuan, Wang, Kehui, Edwards, Robert, Yeung, Anthony, Gelincik, Ozkan, Manfredi, Giovanni, Gross, Steven, Kopelovich, Levy, Lipkin, Steven
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ethylmalonic Encephalopathy Protein 1 ( ) is a sulfur dioxygenase that regulates cellular H S levels. We previously demonstrated a significant increase of expression in "single-hit" colon epithelial cells from crypts of patients with Familial Adenomatous Polyposis (FAP). Here, we report elevated levels of expression and increased mitochondrial density occurring in-situ in phenotypically normal FAP colorectal mucosa. We also found that constitutive expression of increased aerobic glycolysis ("Warburg effect"), oxidative phosphorylation, and mitochondrial biogenesis in colorectal cancer (CRC) cell lines, thereby depleting H S which relieved the inhibition of phosphodiesterase (PDE), and increased adenosine monophosphate (AMP) levels. This led to activation of the energy sensing AMP-activated protein kinase (AMPKp), Sirtuin1 (SIRT1) and peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), a master regulator of mitochondrial biogenesis. By contrast, shRNA silencing of reduced PDE activity, AMPKp/SIRT1/PGC1α levels and mitochondrial biogenesis. Constitutive expression of accelerated both CRC cell xenograft and orthotopic patient derived xenograft CRC cell growth . Overall, our data nominate elevated as a novel biomarker and potential therapeutic target for the prevention of CRC tumorigenesis.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.26958